Članki z zahtevami za javni dostop - Ben A. Bahr, Ph.D.Več o tem
SkupnoNIHDoDAlzheimers's UKSNSFTelethonFCTSwedish Research CouncilBBSRCCancer Research UKMRCNational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKNIHRParkinson's UKWellcomeWorldwide Cancer Research, UKFondazione CariploDoris Duke Charitable FoundationGovernment of SpainGovernment of ItalyJDRF
Ni na voljo nikjer: 1
Lifestyle strategies to promote proteostasis and reduce the risk of Alzheimer’s disease and other proteinopathies
MF Almeida, KLG Farizatto, RS Almeida, BA Bahr
Ageing Research Reviews 93, 102162, 2024
Zahteve: US National Institutes of Health, Alzheimers's UK
Na voljo nekje: 31
Guidelines for the use and interpretation of assays for monitoring autophagy
D Klionsky, F Abdalla, H Abeliovich, R Abraham, A Acevedo-Arozena, ...
Autophagy 8 (4), 445-544, 2014
Zahteve: Swiss National Science Foundation, US National Institutes of Health, UK …
Endo-lysosomal dysfunction: a converging mechanism in neurodegenerative diseases
C Wang, MA Telpoukhovskaia, BA Bahr, X Chen, L Gan
Current opinion in neurobiology 48, 52-58, 2018
Zahteve: US National Institutes of Health
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality
J Hwang, C Adamson, D Butler, DR Janero, A Makriyannis, BA Bahr
Life sciences 86 (15-16), 615-623, 2010
Zahteve: US National Institutes of Health
Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models
D Butler, J Hwang, C Estick, A Nishiyama, SS Kumar, C Baveghems, ...
PloS one 6 (6), e20501, 2011
Zahteve: US National Institutes of Health
Glutamate-induced and NMDA receptor-mediated neurodegeneration entails P2Y1 receptor activation
AP Simões, CG Silva, JM Marques, D Pochmann, LO Porciúncula, ...
Cell death & disease 9 (3), 297, 2018
Zahteve: Fundação para a Ciência e a Tecnologia, Portugal, Government of Spain
Purkinje neuron Ca2+ influx reduction rescues ataxia in SCA28 model
F Maltecca, E Baseggio, F Consolato, D Mazza, P Podini, SM Young, ...
The Journal of clinical investigation 125 (1), 263-274, 2015
Zahteve: Fondazione Telethon, Italy, Fondazione Cariplo, Government of Italy
Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase–dual targets of the endocannabinoid system to protect against seizure pathology
V Naidoo, DA Karanian, SK Vadivel, JR Locklear, JAT Wood, M Nasr, ...
Neurotherapeutics 9 (4), 801-813, 2012
Zahteve: US National Institutes of Health
Positive lysosomal modulation as a unique strategy to treat age-related protein accumulation diseases
BA Bahr, ML Wisniewski, D Butler
Rejuvenation research 15 (2), 189-197, 2012
Zahteve: US National Institutes of Health
A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity
V Naidoo, SP Nikas, DA Karanian, J Hwang, J Zhao, JAT Wood, ...
Journal of Molecular Neuroscience 43, 493-502, 2011
Zahteve: US National Institutes of Health
Z-Phe-Ala-diazomethylketone (PADK) disrupts and remodels early oligomer states of the Alzheimer disease Aβ42 protein
X Zheng, MM Gessel, ML Wisniewski, K Viswanathan, DL Wright, BA Bahr, ...
Journal of Biological Chemistry 287 (9), 6084-6088, 2012
Zahteve: US National Institutes of Health
Spatiotemporal resolution of BDNF neuroprotection against glutamate excitotoxicity in cultured hippocampal neurons
CV Melo, S Okumoto, JR Gomes, MS Baptista, BA Bahr, WB Frommer, ...
Neuroscience 237, 66-86, 2013
Zahteve: US National Institutes of Health
The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer’s Disease and Parkinson’s Disease and Models of Mild Cognitive …
J Hwang, CM Estick, US Ikonne, D Butler, MC Pait, LH Elliott, S Ruiz, ...
International journal of molecular sciences 20 (18), 4432, 2019
Zahteve: US Department of Defense, US National Institutes of Health, Alzheimers's UK
Aβ42-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk …
KLG Farizatto, US Ikonne, MF Almeida, MFR Ferrari, BA Bahr
PLoS One 12 (8), e0182895, 2017
Zahteve: US National Institutes of Health, Alzheimers's UK
Gephyrin interacts with the glutamate receptor interacting protein 1 isoforms at GABAergic synapses
W Yu, EI Charych, DR Serwanski, R Li, R Ali, BA Bahr, AL De Blas
Journal of neurochemistry 105 (6), 2300-2314, 2008
Zahteve: US National Institutes of Health
Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease
DI Carrasco, BA Bahr, KL Seburn, MJ Pinter
Experimental neurology 278, 116-126, 2016
Zahteve: US National Institutes of Health
Submicromolar Aβ42 reduces hippocampal glutamate receptors and presynaptic markers in an aggregation-dependent manner
ML Wisniewski, J Hwang, BA Bahr
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (12 …, 2011
Zahteve: US National Institutes of Health
Nuclear translocation and calpain-dependent reduction of Bcl-2 after neonatal cerebral hypoxia–ischemia
C Zhu, U Hallin, Y Ozaki, R Grandér, K Gatzinsky, BA Bahr, JO Karlsson, ...
Brain, behavior, and immunity 24 (5), 822-830, 2010
Zahteve: Swedish Research Council
Blast waves from detonated military explosive reduce GluR1 and synaptophysin levels in hippocampal slice cultures
M Smith, T Piehler, R Benjamin, KL Farizatto, MC Pait, MF Almeida, ...
Experimental neurology 286, 107-115, 2016
Zahteve: US National Institutes of Health
Discovery of small molecules that normalize the transcriptome and enhance cysteine cathepsin activity in progranulin-deficient microglia
MA Telpoukhovskaia, K Liu, FA Sayed, JI Etchegaray, M Xie, L Zhan, Y Li, ...
Scientific reports 10 (1), 13688, 2020
Zahteve: US National Institutes of Health, Alzheimers's UK
Podatke o objavi in financiranju samodejno določi računalniški program